Up-regulation of carnitine transporters helps maintain tissue carnitine levels in carnitine deficiency induced by pivalic acid

Pharmaceutical Research

Volumn 18, Issue 4, 2001, Pages 439-445

  Okudaira, N ^a   Fujigaki, M ^a   Nakayoshi, T ^a   Komiya, I ^a   Sugiyama, Y ^b  

^a MEIJI SEIKA KAISHA LTD   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Carnitine; Carnitine transporter; Pivalic acid; Tissue uptake

Indexed keywords

CARNITINE; CARNITINE DERIVATIVE; CARNITINE TRANSPORTER; CARRIER PROTEIN; PIVALIC ACID; PIVALOYLCARNITINE; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CARNITINE DEFICIENCY; CLEARANCE; CONTROLLED STUDY; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; KIDNEY; LIVER; LIVER CELL; MALE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE LEVEL;

ANIMALS; CARNITINE; CARRIER PROTEINS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MALE; ORGANIC CATION TRANSPORT PROTEINS; PENTANOIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 0034948622     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011042008169     Document Type: Article

References (30)

1. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2
2. Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice
3. Characteristics of L-carnitine transport in cultured human hepatoma HLF cells
4. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter
5. Pivampicillin-promoted excretion of pivaloylcarnitine in humans
6. Editorials, Carnitine deficiency
7. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy
8. Effect of pivalic acid-containing prodrugs on carnitine homeostasis and on response to fasting in children
9. Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients
10. Safety and carnitine status after oral administration of S-1108 to pediatric patients
11. Carnitine status and safety after administration of S-1108, a new oral cephem, to patients
12. Determination of pivaloylcarnitine in human plasma and urine by high-performance liquid chromatography with fluorescence detection
13. Identification of tissues responsible for the conjugative metabolism of liquiritigenin in rats: An analysis based on metabolite kinetics
14. +-independent multispecific anion transporter mediates active transport of pravastatin in rat liver
15. Kinetic studies on the deethylation of ethoxybenzamide: A comparative study with isolated hepatocytes and liver microsomes of rats
16. Physiological parameters in humans and animals
17. Determination of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine in human plasma by high-performance liquid chromatography after pre-column derivatization with 1-aminoanthracene
18. Disposition of L-carnitine and acetyl-L-carnitine in the isolated perfused rat kidney
19. Turnover of carnitine by rat tissues
20. Sodium pivalate treatment reduces tissue carnitines and enhances ketosis in rats
21. Bioavailability of cefditoren and pivalic acid in cefditoren pivoxil treated dogs: From toxicokinetic point of view
22. Reduced carnitine and ketogenesis in the pivampicillin treated rat
23. Carnitine transport and tissue carnitine accretion in rats
24. Loss of wild-type carrier-mediated L-carnitine transport activity in hepatocytes of juvenile visceral steatosis mice
25. Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine
26. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2) an organic cation/carnitine transporter
27. Characterization of carnitine transport in isolated perfused adult rat hearts
28. Carnitine movement across muscle cell membranes
29. Formation of pivaloylcarnitine in heart and brown adipose tissue in the rat
30. Formation of pivaloylcarnitine in isolated rat heart cells